The Connex Cardio ECG demonstrates exceptional usability with advanced analysis and interpretation SANTA CLARA, California, Nov. 1, 2018 /PRNewswire/ — Based on its recent analysis Continue Reading
admin
Editorial administrator
Ping An Good Doctor Chairman and CEO Mr. Wang Tao Awarded ‘China Industry Leader of the Year’ by Hurun Report; Leading the Innovation of Health-Tech
BEIJING, Nov. 3, 2018 /PRNewswire/ — The 2018 Most Respected Entrepreneurs Awards Dinner, an event hosted by Hurun Report each year, was held in Beijing on Continue Reading
HKSTP Showcases Hong Kong’s Innovation and Technology Edge at Think Global Think Hong Kong
Hong Kong Science Park serves as the platform for fostering international technological exchange and co-creation in I&T HONG KONG, Nov. 1, 2018 /PRNewswire/ — Hong Continue Reading
China Biologic Reports Financial Results for the Third Quarter of 2018
3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms; Continue Reading
Strategic Cooperation between GeneQuantum Healthcare and Biocytogen on Development of Antitumor Bioconjugates
SUZHOU, China, Nov. 1, 2018 /PRNewswire/ — GeneQuantum Healthcare and Biocytogen reached a Strategic Cooperation Agreement focusing on the development of next generation bioconjugates for Continue Reading
Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
TAIPEI, Taiwan and SAN DIEGO, Nov. 1, 2018 /PRNewswire/ — Senhwa Biosciences Inc. (TPEx: 6492) announced today that FDA has approved its IND application for Continue Reading
L.E.A.F. Pharmaceuticals Receives Positive US FDA Feedback and Comprehensive Roadmap for Clinical Development as well as Registration of its Four Lead Novel Anticancer Drugs
US FDA further indicates that one of the four drugs may be eligible for registration via 505(b)(2) Regulatory Pathway VALLEY FORGE, Pennsylvania, Oct. 30, 2018 Continue Reading
Orion Health Finalizes Investment Deal with Hg
-Rhapsody acquisition completed, Population Health investment secured BOSTON, Oct. 31, 2018 /PRNewswire/ — Orion Health (NZX:OHE/ASX:OHE) today announced the completion of its transaction with technology Continue Reading
CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006
SUZHOU, China, Oct. 30, 2018 /PRNewswire/ — CStone Pharmaceuticals (CStone) today announced the initiation in China of a Phase I clinical trial for CS3006, a Continue Reading
GC Pharma Reports Q3 2018 Results
YONGIN, South Korea, Oct. 30, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results Continue Reading